BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...
Magnetic Resonance Imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated for its non-ionizing and non-invasive nature. With nearly 40% of MRI procedures requiring contrast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback